Defect in phosphorylation of insulin receptors in cells from an insulin-resistant patient with normal insulin binding.

PubWeight™: 1.44‹?› | Rank: Top 5%

🔗 View Article (PMID 6141638)

Published in Science on March 02, 1984

Authors

G Grunberger, Y Zick, P Gorden

Articles citing this

Replacement of lysine residue 1030 in the putative ATP-binding region of the insulin receptor abolishes insulin- and antibody-stimulated glucose uptake and receptor kinase activity. Proc Natl Acad Sci U S A (1987) 2.99

Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. J Clin Invest (1987) 2.36

A nonsense mutation causing decreased levels of insulin receptor mRNA: detection by a simplified technique for direct sequencing of genomic DNA amplified by the polymerase chain reaction. Proc Natl Acad Sci U S A (1990) 1.90

Insulin action is blocked by a monoclonal antibody that inhibits the insulin receptor kinase. Proc Natl Acad Sci U S A (1986) 1.80

Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects. J Clin Invest (1987) 1.76

Studies on the mechanism of insulin resistance in the liver from humans with noninsulin-dependent diabetes. Insulin action and binding in isolated hepatocytes, insulin receptor structure, and kinase activity. J Clin Invest (1986) 1.67

Protein kinase activity of the insulin receptor. Biochem J (1986) 1.31

Transdominant inhibition of tyrosine kinase activity in mutant insulin/insulin-like growth factor I hybrid receptors. Proc Natl Acad Sci U S A (1991) 1.21

Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. Effect of weight loss. J Clin Invest (1988) 1.18

Identification of a cellular 110 000-Da protein substrate for the insulin-receptor kinase. Biochem J (1985) 1.15

The biochemistry of diabetes. Biochem J (1988) 1.14

An antipeptide antibody that specifically inhibits insulin receptor autophosphorylation and protein kinase activity. Proc Natl Acad Sci U S A (1985) 1.11

Diabetes-induced functional and structural changes in insulin receptors from rat skeletal muscle. J Clin Invest (1986) 1.09

Insulin receptor biosynthesis in cultured lymphocytes from insulin-resistant patients. J Clin Invest (1985) 1.00

Insulin and rabbit anti-insulin receptor antibodies stimulate additively the intrinsic receptor kinase activity. EMBO J (1987) 0.95

Insulin receptor function in fibroblasts from patients with leprechaunism. Differential alterations in binding, autophosphorylation, kinase activity, and receptor-mediated internalization. J Clin Invest (1988) 0.93

Structural analysis of normal and mutant insulin receptors in fibroblasts cultured from families with leprechaunism. Am J Hum Genet (1987) 0.91

Insulin resistance, selfish brain, and selfish immune system: an evolutionarily positively selected program used in chronic inflammatory diseases. Arthritis Res Ther (2014) 0.91

Relationship of insulin binding and insulin-stimulated tyrosine kinase activity is altered in type II diabetes. J Clin Invest (1987) 0.90

Topiramate-induced modulation of hepatic molecular mechanisms: an aspect for its anti-insulin resistant effect. PLoS One (2012) 0.88

Tauroursodeoxycholic acid attenuates lipid accumulation in endoplasmic reticulum-stressed macrophages. J Cardiovasc Pharmacol (2010) 0.85

Molecular genetics of severe insulin resistance. Yale J Biol Med (1990) 0.83

Insulin receptor of human cerebral gliomas. Structure and function. J Clin Invest (1986) 0.80

Insulin receptors and the clinician. Br Med J (Clin Res Ed) (1986) 0.79

Antibodies to insulin receptor tyrosine kinase stimulate its activity towards exogenous substrates without inducing receptor autophosphorylation. Biochem J (1989) 0.78

Defective processing of insulin-receptor precursor in cultured lymphocytes from a patient with extreme insulin resistance. J Clin Invest (1988) 0.75

Articles by these authors

The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. N Engl J Med (1976) 5.09

Epidermal growth factor: morphological demonstration of binding, internalization, and lysosomal association in human fibroblasts. Proc Natl Acad Sci U S A (1978) 4.03

Insulin stimulates tyrosine phosphorylation of the insulin receptor in a cell-free system. Nature (1982) 3.90

Ligands internalized through coated or noncoated invaginations follow a common intracellular pathway. Proc Natl Acad Sci U S A (1987) 3.33

Forty-eight-hour fast: the diagnostic test for insulinoma. J Clin Endocrinol Metab (2000) 2.75

Characteristics of the human lymphocyte insulin receptor. J Biol Chem (1973) 2.61

Insulin stimulation of phosphorylation of the beta subunit of the insulin receptor. Formation of both phosphoserine and phosphotyrosine. J Biol Chem (1982) 2.58

A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J Biol Chem (1997) 2.50

125I-insulin binding to cultured human lymphocytes. Initial localization and fate of hormone determined by quantitative electron microscopic autoradiography. J Clin Invest (1978) 2.47

Fluctuations in the affinity and concentration of insulin receptors on circulating monocytes of obese patients: effects of starvation, refeeding, and dieting. J Clin Invest (1976) 2.12

Localization of insulinomas to regions of the pancreas by intra-arterial stimulation with calcium. Ann Intern Med (1995) 2.05

The insulinomimetic agents H2O2 and vanadate stimulate protein tyrosine phosphorylation in intact cells. J Biol Chem (1990) 2.03

Benign metastasizing leiomyoma of the uterus: documentation of clinical, immunohistochemical and lectin-histochemical data of ten cases. Virchows Arch (2000) 1.97

Defect in insulin binding to receptors in obese man. Amelioration with calorie restriction. J Clin Invest (1975) 1.92

Co-localization of 125I-epidermal growth factor and ferritin-low density lipoprotein in coated pits: a quantitative electron microscopic study in normal and mutant human fibroblasts. J Cell Biol (1982) 1.88

Glucose intolerance in cystic fibrosis. N Engl J Med (1969) 1.85

The effect of tyrosine-specific protein phosphorylation on the assembly of adherens-type junctions. EMBO J (1992) 1.85

Efficacy of conventional pituitary irradiation in acromegaly. N Engl J Med (1970) 1.82

Localization and surgical treatment of occult insulinomas. Ann Surg (1990) 1.76

Efficacy of leptin therapy in the different forms of human lipodystrophy. Diabetologia (2009) 1.75

Insulin resistance: a phosphorylation-based uncoupling of insulin signaling. Trends Cell Biol (2001) 1.75

Pathogenesis of congenital alkalosis with diarrhea. Implications for the physiology of normal ileal electrolyte absorption and secretion. J Clin Invest (1972) 1.73

Insulin receptors in human circulating lymphocytes: application to the study of insulin resistance in man. J Clin Endocrinol Metab (1973) 1.71

Impairment of insulin binding to the fat cell plasma membrane in the obese hyperglycemic mouse. FEBS Lett (1972) 1.71

Elevated plasma adiponectin in humans with genetically defective insulin receptors. J Clin Endocrinol Metab (2006) 1.71

"Big insulin": a new component of plasma insulin detected by immunoassay. Proc Natl Acad Sci U S A (1968) 1.67

Intracellular translocation of iodine-125-labeled insulin: direct demonstration in isolated hepatocytes. Science (1978) 1.66

Lysosomal association of internalized 125I-insulin in isolated rat hepatocytes. Direct demonstration by quantitative electron microscopic autoradiography. J Clin Invest (1979) 1.63

Binding of 125I-human growth hormone to specific receptors in human cultured lymphocytes. Characterization of the interaction and a sensitive radioreceptor assay. J Biol Chem (1974) 1.63

Characterization of insulin-mediated phosphorylation of the insulin receptor in a cell-free system. J Biol Chem (1983) 1.62

Phosphorylation of insulin receptor substrate-1 (IRS-1) by protein kinase B positively regulates IRS-1 function. J Biol Chem (1999) 1.60

Insulinomas: localization with selective intraarterial injection of calcium. Radiology (1991) 1.58

Insulin stimulates PKCzeta -mediated phosphorylation of insulin receptor substrate-1 (IRS-1). A self-attenuated mechanism to negatively regulate the function of IRS proteins. J Biol Chem (2001) 1.54

Modulation of intercellular adherens-type junctions and tyrosine phosphorylation of their components in RSV-transformed cultured chick lens cells. Cell Regul (1991) 1.53

Affinity alteration of insulin receptor induced by a phorbol ester. Am J Physiol (1982) 1.51

Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level. Mol Endocrinol (1993) 1.50

Internalization of polypeptide hormones: mechanism, intracellular localization and significance. Diabetologia (1980) 1.49

Receptors for insulin, NSILA-s, and growth hormone: applications to disease states in man. Recent Prog Horm Res (1975) 1.47

Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis. J Cell Sci (2000) 1.47

Human growth hormone radioreceptor assay using cultured human lymphocytes. Nat New Biol (1973) 1.43

Immunoassay of plasma vasopressin in man. Proc Natl Acad Sci U S A (1970) 1.43

The role of antireceptor antibodies in stimulating phosphorylation of the insulin receptor. J Biol Chem (1984) 1.43

Expression of two human growth hormone genes in monkey cells infected by simian virus 40 recombinants. Proc Natl Acad Sci U S A (1981) 1.39

Insulin receptor defect in insulin resistance: studies in the obese-hyperglycimic mouse. Biochem Biophys Res Commun (1972) 1.39

Proinsulin C-peptide--a consensus statement. Int J Exp Diabetes Res (2001) 1.38

Acromegaly and cardiovascular disorders. A prospective study. Ann Intern Med (1974) 1.37

Diabetes and related metabolic risk factors among Arab Americans. Ann Pharmacother (1995) 1.36

Galectin-8 functions as a matricellular modulator of cell adhesion. J Biol Chem (2001) 1.34

Pancreatic cholera: benefical effects of treatment with streptozotocin. N Engl J Med (1975) 1.32

Morphological changes of the 3T3-L1 fibroblast plasma membrane upon differentiation to the adipocyte form. J Cell Sci (1983) 1.32

Binding and internalization of 125I-LDL in normal and mutant human fibroblasts. A quantitative autoradiographic study. Exp Cell Res (1979) 1.32

Metastatic insulin-secreting carcinoma of the pancreas: clinical course and the role of surgery. Surgery (1984) 1.30

Receptor-mediated endocytosis of insulin: role of microvilli, coated pits, and coated vesicles. Proc Natl Acad Sci U S A (1982) 1.30

Recent advances in our understanding of insulin action and insulin resistance. Diabetes Care (2001) 1.29

Treatment of type B insulin resistance: a novel approach to reduce insulin receptor autoantibodies. J Clin Endocrinol Metab (2010) 1.29

NIH conference. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut. Ann Intern Med (1989) 1.28

Multisite phosphorylation of the alpha subunit of transducin by the insulin receptor kinase and protein kinase C. Proc Natl Acad Sci U S A (1986) 1.28

Surface redistribution of 125I-insulin in cultured human lymphocytes. J Cell Biol (1981) 1.27

Intraoperative ultrasonographic localization of islet cell tumors. A prospective comparison to palpation. Ann Surg (1988) 1.27

Recurrent hematuria and focal nephritis. N Engl J Med (1967) 1.27

Hypoglycemia associated with non-islet-cell tumor and insulin-like growth factors. N Engl J Med (1981) 1.26

Alpha2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor. Mol Cell Endocrinol (2000) 1.23

Selective inhibition of protein tyrosine phosphatase activities by H2O2 and vanadate in vitro. Biochem Biophys Res Commun (1992) 1.23

Insulin stimulated phosphorylation of its own receptor. Activation of a tyrosine-specific protein kinase that is tightly associated with the receptor. J Biol Chem (1983) 1.22

Familial hyperproinsulinemia due to a proposed defect in conversion of proinsulin to insulin. N Engl J Med (1984) 1.20

Galectin-8. A new rat lectin, related to galectin-4. J Biol Chem (1995) 1.20

Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus. Circulation (1999) 1.19

Receptor aggregation is necessary for activation of the soluble insulin receptor kinase. J Biol Chem (1986) 1.19

A sensitive radioimmunoassay for 7S nerve growth factor antigens in serum and tissues. J Neurochem (1971) 1.19

Bovine fetuin is an inhibitor of insulin receptor tyrosine kinase. Life Sci (1997) 1.19

Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migration. Brain Pathol (2001) 1.17

Five mutant alleles of the insulin receptor gene in patients with genetic forms of insulin resistance. J Clin Invest (1990) 1.17

The insulin receptor of a human monocyte-like cell line: characterization and function. Endocrinology (1984) 1.16

Insulin and insulinomimetic agents induce activation of phosphatidylinositol 3'-kinase upon its association with pp185 (IRS-1) in intact rat livers. J Biol Chem (1992) 1.15

Hepatitis from methimazole during adrenal steroid therapy for malignant exophthalmos. JAMA (1968) 1.14

The reliability of the Diabetes Care Profile for African Americans. Eval Health Prof (1998) 1.14

Glucose intolerance with hypokalemia. Failure of short-term potassium depletion in normal subjects to reproduce the glucose and insulin abnormalities of clinical hypokalemia. Diabetes (1973) 1.14

Insulin-induced surface redistribution regulates internalization of the insulin receptor and requires its autophosphorylation. Proc Natl Acad Sci U S A (1992) 1.13

Polypeptide hormone degradation and receptor regulation are coupled to ligand internalization. A direct biochemical and morphologic demonstration. J Biol Chem (1981) 1.12

Once- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes. Diabetes Care (2001) 1.12

Hypoglycemia in association with extrapancreatic tumors: demonstration of elevated plasma NSILA-s by a new radioreceptor assay. J Clin Endocrinol Metab (1974) 1.12

Tyrosine phosphorylation of insulin receptor substrate-1 in vivo depends upon the presence of its pleckstrin homology region. J Biol Chem (1995) 1.12

Results of a prospective strategy to diagnose, localize, and resect insulinomas. Surgery (1991) 1.11

Plasma insulin: fluctuations in the "big" insulin component in man after glucose and other stimuli. J Clin Invest (1969) 1.10

Factitious hypoglycemia due to surreptitious administration of insulin. Diagnosis, treatment, and long-term follow-up. Ann Intern Med (1988) 1.10

Regulation of insulin receptors in normal and abnormal physiology in humans. Adv Intern Med (1979) 1.10

Intraarterial calcium stimulation and intraoperative ultrasonography in the localization and resection of insulinomas. Surgery (1997) 1.10

Intracellular localization of 125I-labeled insulin in hepatocytes from intact rat liver. Proc Natl Acad Sci U S A (1979) 1.09

Circulating insulins. "Big" and "little". Arch Intern Med (1969) 1.09

Insulin resistance associated with androgen excess in women with autoantibodies to the insulin receptor. Ann Intern Med (1982) 1.09

Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor. Gut (2002) 1.09

Insulin-like growth factor-I (IGF-I) stimulates tyrosine kinase activity in purified receptors from a rat liver cell line. Biochem Biophys Res Commun (1984) 1.09

Potassium depletion and hypertonic medium reduce "non-coated" and clathrin-coated pit formation, as well as endocytosis through these two gates. J Cell Physiol (1989) 1.07

Rabbit uterus as a source of renin. Am J Physiol (1967) 1.07

Syndromes of autoimmunity and hypoglycemia. Autoantibodies directed against insulin and its receptor. Endocrinol Metab Clin North Am (1989) 1.07

Conventional supervoltage irradiation is an effective treatment for acromegaly. J Clin Endocrinol Metab (1979) 1.07